Corporate News – Market Update on Larimar Therapeutics (LRMR)
Trading Activity
- Larimar Therapeutics shares closed at USD 2.46 on major exchanges as of 07:47 PM Central Europe, Wednesday 21st.
- The stock advanced 15.09 % during the 24‑hour period ending at that time.
- In the preceding 24 hours, approximately USD 4.4 million of LRMR shares were traded.
Supply and Capitalization
- Shares outstanding: 104.4 million.
- Market capitalization: USD 221.3 million.
- Simple moving average (200 days): USD 3.84.
Historical Performance
- Highest price in the last 52 weeks: USD 6.42 (recorded 25 February 2026).
- Lowest price in the last 52 weeks: USD 1.92 (recorded 16 October 2026).
- Since the end of the previous month, the stock has declined 36.29 %.
Comparative Performance of Related Stocks (Last 24 Hours)
| Ticker | Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|
| OACC | +0.09 % | USD 10.68 | USD 261.8 M | 39.09 |
| DMAA | 0 % | USD 10.86 | USD 263.9 M | 58.21 |
| HWBK | +1.52 % | USD 38.18 | USD 263.1 M | 10.38 |
| RWAY | +0.32 % | USD 6.33 | USD 261.5 M | 32.59 |
| NCZ-PA | –0.25 % | USD 18.10 | USD 262.8 M | 3.63 |
Company Overview
Larimar Therapeutics, Inc. is a biotechnology firm focused on the development and discovery of treatments for rare complex diseases, including protein replacement therapy. The company operates within the Health Care sector and is headquartered in Bala Cynwyd, United States, serving primarily the Pennsylvania region. Additional information can be accessed via the company’s official website, www.larimartx.com , or through trading on the Nasdaq stock exchange.
